Skip to content

Treatment of Central Sleep Apnea Syndrome with low-pressure nasal continuous positive airway pressure and rebreathing.

Treatment of Central Sleep Apnea Syndrome with low-pressure nasal continuous positive airway pressure and rebreathing. - CSAS treated with rebreathing and nCPAP.

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39400
Enrollment
10
Registered
2012-10-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sleep apnea

Interventions

Each patient acts as his or her own control and receives 5 Pairs of treatments. Each pair consist of one night treatment with low pressure CPAP with added dead space(rebreathing) and a one night tre

Sponsors

Medisch Centrum Alkmaar
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: outpatients diagnosed with central sleep apnea syndrome by polysomnography with sleep apnea index *15 and at least 50% of all apneas is central in origin without obstructieve components. Age 18-80 years Patients are using or have been using CPAP. Informed Consent

Exclusion criteria

Exclusion criteria: History of heart failure, cardiac arrhythmia or cardiac ischemia, History of stroke Cheyne Stokes breathing during daytime, Sedatives or hypnotic agents, opioids., Respiratory failure( hypoxia, hypercapnia or respiratory acidosis during daytime) Pulmonary diseases Body mass index * 30 Untreated thyroid disease pregnancy

Design outcomes

Primary

MeasureTime frame
Primary study parameters/endpoints Apnea Hypopnea Index with low-pressure nCPAP and added dead space versus low-pressure nCPAP only

Secondary

MeasureTime frame
Secondary study parameters/endpoints * Blood pressure measured during low-pressure nCPAP with added dead space and low-pressure nCPAP only. * Sleep structure during low-pressure nCPAP with added dead space and low-pressure nCPAP only. * Subjective quality of sleep during low-pressure nCPAP with added dead space and low-pressure nCPAP only. * Heartrate variability during low-pressure nCPAP with added dead space and low-pressure nCPAP only.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)